Literature DB >> 22553255

Macrolides for acute lung injury.

Michael J Noto1, Arthur P Wheeler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22553255      PMCID： PMC3342786          DOI： 10.1378/chest.11-3245

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  12 in total

1.  Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.

Authors:  José A Martínez; Juan P Horcajada; Manuel Almela; Francesc Marco; Alex Soriano; Elisa García; Maria Angeles Marco; Antoni Torres; Josep Mensa
Journal:  Clin Infect Dis       Date:  2003-01-31       Impact factor: 9.079

2.  Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome.

Authors: 
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

Review 3.  Chronic macrolide therapy in inflammatory airways diseases.

Authors:  Adam L Friedlander; Richard K Albert
Journal:  Chest       Date:  2010-11       Impact factor: 9.410

4.  Azithromycin for prevention of exacerbations of COPD.

Authors:  Richard K Albert; John Connett; William C Bailey; Richard Casaburi; J Allen D Cooper; Gerard J Criner; Jeffrey L Curtis; Mark T Dransfield; Meilan K Han; Stephen C Lazarus; Barry Make; Nathaniel Marchetti; Fernando J Martinez; Nancy E Madinger; Charlene McEvoy; Dennis E Niewoehner; Janos Porsasz; Connie S Price; John Reilly; Paul D Scanlon; Frank C Sciurba; Steven M Scharf; George R Washko; Prescott G Woodruff; Nicholas R Anthonisen
Journal:  N Engl J Med       Date:  2011-08-25       Impact factor: 91.245

5.  Diffuse panbronchiolitis: follow-up CT examination.

Authors:  M Akira; T Higashihara; M Sakatani; H Hara
Journal:  Radiology       Date:  1993-11       Impact factor: 11.105

6.  Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones.

Authors:  Mark L Metersky; Allen Ma; Peter M Houck; Dale W Bratzler
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

7.  Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

Authors:  Lisa Saiman; Bruce C Marshall; Nicole Mayer-Hamblett; Jane L Burns; Alexandra L Quittner; Debra A Cibene; Sarah Coquillette; Ann Yunker Fieberg; Frank J Accurso; Preston W Campbell
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

Review 8.  Acute lung injury and the acute respiratory distress syndrome: a clinical review.

Authors:  Arthur P Wheeler; Gordon R Bernard
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

9.  Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia.

Authors:  Evangelos J Giamarellos-Bourboulis; Jean-Claude Pechère; Christina Routsi; Diamantis Plachouras; Spyridon Kollias; Maria Raftogiannis; Dimitrios Zervakis; Fotini Baziaka; Apostolos Koronaios; Anastasia Antonopoulou; Vassiliki Markaki; Pantelis Koutoukas; Evangelos Papadomichelakis; Thomas Tsaganos; Apostolos Armaganidis; Vassilios Koussoulas; Anastasia Kotanidou; Charis Roussos; Helen Giamarellou
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

10.  Effect of erythromycin on endotoxin-induced microvascular leakage in the rat trachea and lungs.

Authors:  J Tamaoki; E Tagaya; I Yamawaki; N Sakai; A Nagai; K Konno
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405
View more
  3 in total

Review 1.  Reducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department.

Authors:  Brian M Fuller; Nicholas M Mohr; Richard S Hotchkiss; Marin H Kollef
Journal:  Shock       Date:  2014-05       Impact factor: 3.454

Review 2.  Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.

Authors:  Helen C Steel; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2013-12-25       Impact factor: 4.711

Review 3.  Key mechanisms governing resolution of lung inflammation.

Authors:  C T Robb; K H Regan; D A Dorward; A G Rossi
Journal:  Semin Immunopathol       Date:  2016-04-27       Impact factor: 9.623
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.